Related Experiment Video

Updated: May 17, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Advances in treatment of bacterial meningitis

Diederik van de Beek1, Matthijs C Brouwer, Guy E Thwaites

  • 1Department of Neurology, Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands. d.vandebeek@amc.uva.nl

Lancet (London, England)
|November 13, 2012
PubMed

Insights

Bacterial meningitis poses a significant threat, with rising antibiotic resistance complicating treatment. This review explores optimizing antibiotic efficacy and evaluating adjunctive therapies for better patient outcomes.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Bacterial meningitis is a severe infection with high mortality and morbidity rates.
  • The emergence of multidrug-resistant bacteria compromises the effectiveness of standard antibiotic treatments.
  • Adjunctive therapies like dexamethasone have controversial efficacy, particularly in resource-limited settings.

Purpose of the Study:

  • To review the therapeutic challenges posed by bacterial meningitis.
  • To focus on strategies for optimizing antibiotic efficacy against drug-resistant bacteria.
  • To discuss the role of current and emerging adjunctive therapies.

Main Methods:

  • Literature review of existing studies on bacterial meningitis treatment.
  • Analysis of antibiotic resistance trends and their impact on treatment efficacy.
  • Evaluation of clinical data on adjunctive therapies, including dexamethasone, glycerol, paracetamol, and hypothermia.

Main Results:

  • Early antibiotic treatment is crucial but increasingly challenged by multidrug-resistant pathogens.
  • The efficacy of new antibiotics like fluoroquinolones requires further clinical validation.
  • Adjunctive anti-inflammatory treatments, such as dexamethasone, show limited benefit and are ineffective in certain populations.

Conclusions:

  • Bacterial meningitis remains a significant and evolving therapeutic challenge.
  • Optimizing antibiotic strategies to combat resistance is essential.
  • Further research into novel adjunctive therapies is needed to improve patient outcomes, especially in high-burden regions.

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...